So-Young International Förvaltning
Förvaltning kriterier kontrolleras 2/4
So-Young International VD är Xing Jin, utsedd i Mar 2013, har en anställningstid på 13.33 år. äger direkt 24.95% av företagets aktier, värda $ 46.08M. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 7.4 år respektive 4.5 år.
Viktig information
Xing Jin
Verkställande direktör
n/a
Total ersättning
| VD-lön i procent | n/a |
| Anställning som VD | 13.3yrs |
| Ägande av VD | 24.9% |
| Ledningens genomsnittliga anställningstid | 7.4yrs |
| Styrelsens genomsnittliga mandatperiod | 4.5yrs |
Senaste uppdateringar av ledningen
Recent updates
Uppdatering av berättelse • Jul 07
SY: Future Share Buybacks And Earnings Framework Will Drive Repricing
Analysts have raised their price target on So-Young International to $4.81 from $1.54, citing updated assumptions around fair value, discount rate, revenue growth, profit margin, and a future P/E framework. What’s in the News for So-Young International So-Young International issued revenue guidance for Q2 2026, projecting aesthetic treatment services revenues between RMB 307.0 million (US$44.5 million) and RMB 317.0 million (US$46.0 million), based on the company’s current estimates of market conditions and customer demand.
Uppdatering av berättelse • Jun 23
SY: Lower Impairments And Buybacks Will Support Future Upside
Analysts have kept their price target for So-Young International steady at $7.31, citing unchanged fair value, revenue growth, profit margin, and future P/E assumptions, despite a slightly higher discount rate in their models. What’s in the News for So-Young International So-Young International issued revenue guidance for the second quarter of 2026, expecting aesthetic treatment services revenues between RMB 307.0 million (US$44.5 million) and RMB 317.0 million (US$46.0 million), based on current market conditions and preliminary internal estimates.Uppdatering av berättelse • Jun 06
SY: Lower Impairments And Extended Buybacks Will Support Future Upside
Analysts have revised their price target for So-Young International to $7.31 from $7.60, citing updated assumptions around revenue growth, profit margins, discount rates, and future P/E expectations. What's in the News So-Young International issued revenue guidance for the second quarter of 2026, projecting aesthetic treatment services revenue between RMB 307.0 million (US$44.5 million) and RMB 317.0 million (US$46.0 million), based on current market conditions and preliminary estimates of customer demand.Uppdatering av berättelse • May 04
SY: Lower Impairments And Extended Buybacks Will Support Future Upside
Analysts have kept their $7.60 price target for So-Young International broadly unchanged, pointing to only minor tweaks in inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions, rather than any major shift in their view on the stock. What's in the News For the fourth quarter ended December 31, 2025, So-Young International reported unaudited impairment of goodwill and long-lived assets of RMB 19,710,000 compared with RMB 540,009,000 a year earlier (company filing).Uppdatering av berättelse • Apr 19
SY: Lower Impairments And Extended Buybacks Will Support Future Upside
Analysts have trimmed their price target on So-Young International, reflecting updated assumptions that include a fair value estimate of $7.60, a revenue growth outlook of 29.36%, a profit margin of 1.65%, and a future P/E of 125.51, as they reassess the balance between growth expectations and profitability. What's in the News So-Young International reported unaudited consolidated impairment charges for the fourth quarter ended December 31, 2025, with impairment of goodwill and long-lived assets of RMB 19,710,000, compared with RMB 540,009,000 a year earlier (Key Developments).Uppdatering av berättelse • Feb 04
SY: Interim CFO Move And Steady Outlook Will Support Future Upside
Analysts have modestly adjusted their price target on So-Young International, reflecting small tweaks to inputs such as a slightly lower discount rate, steady fair value at about $7.74, and a marginally revised future P/E assumption based on their latest review of the company’s risk and growth profile. What's in the News Chief financial officer Hui Zhao has submitted his resignation from So-Young International, with his role ending on December 31, 2025, citing personal reasons (Key Developments).Uppdatering av berättelse • Jan 20
SY: Stable CFO Transition And Solid Guidance Will Support Future Earnings Multiple
Analysts have trimmed their price target on So-Young International slightly, citing small adjustments to the discount rate, profit margin outlook, and assumed future P/E multiple, while keeping fair value and revenue growth expectations broadly unchanged. What's in the News So-Young International received a resignation notice from chief financial officer Hui Zhao, who plans to step down effective December 31, 2025, citing personal reasons (company announcement).Uppdatering av berättelse • Jan 06
SY: Higher Profitability Assumptions Will Support Stronger Future Earnings Multiple
Analysts have lifted their price target on So-Young International by about 36%, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News So-Young International received a notice of resignation from chief financial officer Hui Zhao, who is set to leave the role effective December 31, 2025, citing personal reasons (Key Developments).Seeking Alpha • Aug 19
So-Young: Turning Positive On Sales Beat And Attractive Valuations (Rating Upgrade)
Summary I upgraded So-Young to "Buy" after its Q2 revenue beat expectations and the stock's post-earnings pullback created an attractive entry point. SY's successful pivot to branded aesthetic centers drove strong sequential sales growth, with this segment now accounting for 38% of total revenue. Despite ongoing losses and disappointing guidance, signs of operational improvement and profitability inflection are evident as clinic network expansion progresses. The stock's valuation is compelling at 1.0x forward EV/S, a discount to historical averages and peers. Read the full article on Seeking AlphaAnalysartikel • Nov 13
Investors Give So-Young International Inc. (NASDAQ:SY) Shares A 34% Hiding
So-Young International Inc. ( NASDAQ:SY ) shareholders that were waiting for something to happen have been dealt a blow...Seeking Alpha • Oct 08
So-Young: Anticipating Both Top-Line Recovery And Margin Pressures
Summary So-Young International's revenue could recover and beat expectations going forward, if China is successful in stimulating the economy and boosting consumer confidence with new policies. SY's margins are expected to be negatively affected by the company's revenue mix shift toward lower-margin product sales and the growth in its clinic network. The mixed outlook warrants a Hold rating for So-Young International. Read the full article on Seeking AlphaAnalysartikel • Sep 27
Potential Upside For So-Young International Inc. (NASDAQ:SY) Not Without Risk
It's not a stretch to say that So-Young International Inc.'s ( NASDAQ:SY ) price-to-earnings (or "P/E") ratio of 17.7x...Analysartikel • Aug 05
Is Now An Opportune Moment To Examine So-Young International Inc. (NASDAQ:SY)?
While So-Young International Inc. ( NASDAQ:SY ) might not have the largest market cap around , it saw significant share...Analysartikel • May 29
Many Still Looking Away From So-Young International Inc. (NASDAQ:SY)
With a price-to-sales (or "P/S") ratio of 0.5x So-Young International Inc. ( NASDAQ:SY ) may be sending bullish signals...Analysartikel • Apr 23
Is Now The Time To Look At Buying So-Young International Inc. (NASDAQ:SY)?
So-Young International Inc. ( NASDAQ:SY ), might not be a large cap stock, but it saw a significant share price rise of...Seeking Alpha • Mar 28
So-Young Dolls Up With Pivot To High-End Services
Summary So-Young reported an annual profit last year, reversing two years of losses, as its revenue rose 19%. The company’s new So-Young Prime service for high-end users helped to fuel a 22.2% revenue jump in its information services segment last year. The company’s evolution towards a more direct provider of cosmetic products and services is still a work in progress. Read the full article on Seeking AlphaAnalysartikel • Feb 19
Market Cool On So-Young International Inc.'s (NASDAQ:SY) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 0.6x So-Young International Inc. ( NASDAQ:SY ) is a stock...Analysartikel • Dec 07
What Is So-Young International Inc.'s (NASDAQ:SY) Share Price Doing?
While So-Young International Inc. ( NASDAQ:SY ) might not be the most widely known stock at the moment, it received a...Seeking Alpha • Sep 12
So-Young International: Tough Times
Summary So-Young International is facing tough times, due to weak economic conditions in China, the COVID-zero policy of the country, and regulatory headwinds for the Chinese medical aesthetics industry. SY saw its revenue decrease for the second straight quarter running in Q2 2022, and it turned from positive net income in Q2 2021 to losses in the recent quarter. On the flip side, So-Young International might deliver quarterly revenue beats in 2H 2022, assuming that the new product, So-Young Select, turns out to be more successful than expected. I have a Hold rating for SY; the new product So-Young Select could be a potential near-term catalyst, but the current operating environment for So-Young International is still too challenging to warrant a Buy rating for SY. Elevator Pitch My initial investment rating for So-Young International Inc.'s (NASDAQ:SY) shares is a Hold. It has been tough times for So-Young International in 2022 year-to-date, as seen with its topline decline for Q1 2022 and Q2 2022. There could be a short-term catalyst for SY in the form of better-than-expected results relating to its new product, So-Young Select. But the intermediate-term outlook for SY is still unfavorable, considering factors like China's macroeconomic environment, and new regulations which have a negative impact on the Chinese medical aesthetics market. Therefore, I think that a Hold (rather than Buy or Sell) rating is justified for So-Young International's stock. Challenging Operating Environment For The Chinese Medical Aesthetics Market So-Young International refers to itself as the operator of "the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry" in its media releases. SY generated 77% of its fiscal 2021 revenue from information services, or fees collected from service providers in exchange for sharing information about their medical aesthetics services in the community, according to its most recent 20-F filing. Reservations services (revenue relating to sales leads for service providers), and the sales of equipment & related maintenance services contributed the remaining 16% and 7% of its topline, respectively last year. Both So-Young International and the medical aesthetics industry in China have faced multiple headwinds in recent times. Firstly, China's economy is expected to slow in the foreseeable future, and this is evidenced by economists revising their 2022 and 2023 GDP growth estimates downwards as highlighted in a recent August 29, 2022 Bloomberg article. Given that medical aesthetics procedures are largely discretionary in nature, it is no surprise that short-term demand for medical aesthetics in China has weakened, and this also translates into lower revenue for So-Young International. Secondly, China appears to be persisting with the country's COVID-zero stance as it stands now. This implies that lockdowns and tighter pandemic restrictions will be seen in different parts of Mainland China from time to time when there is a spike in COVID-19 cases in specific areas. This is very disruptive for the Chinese medical aesthetics industry, where customers might be deterred or restricted from going outdoors to utilize related services. Similarly, users will be less keen to visit So-Young International's online platform and community to be updated on related developments in the medical aesthetics industry in China. Thirdly, the Mainland Chinese aesthetics market is facing significant regulatory pressures. A Reuters news article published a year ago on August 27, 2021 mentioned that "draft guidelines on regulation of the (Chinese) medical aesthetics sector's advertising" were issued with the aim to "crack down on ads that create anxiety over people's looks." Consulting firm Kline also noted in a May 27, 2022 write-up that Chinese regulatory authorities "issued four new regulations to rule out counterfeit products and unqualified institutions from the professional skin care market." While these new regulations were probably put in place with good intentions having the interests of Chinese consumers in mind, they will inevitably have a dampening effect on the growth of the medical aesthetics market in Mainland China. The tough operating conditions for So-Young International are reflected in the company's key recent financial and operating metrics as detailed in the subsequent section of the article. Key Financial And Operating Metrics For SY SY's revenue fell by -31.6% YoY from RMB452 million in the second quarter of 2021 to RMB309 million in the most recent quarter, as indicated in its Q2 2022 earnings press release. This marks the second consecutive quarter of topline contraction for So-Young International; SY's sales also declined by -16.5% YoY in the first quarter of this year. Prior to Q1 2022, So-Young International had delivered positive topline expansion in the seven quarters between Q2 2022 and Q4 2021. Notably, So-Young International's Q2 2022 revenue had benefited from the incremental sales of around RMB59 million contributed by its new sales of equipment & related maintenance services business segment, which was created with the acquisition of Wuhan Miracle Laser System in the prior year. Excluding the impact of the M&A transaction concluded in 2021, SY's adjusted organic revenue decline for the second quarter of the current year would have been even worse at -44.7% YoY (versus headline topline contraction of -31.6%). Also, SY reversed from positive non-GAAP adjusted earnings of +RMB73.7 million in Q2 2021 to record a non-GAAP adjusted net loss of -RMB22.7 million for Q2 2022. One key contributing factor is the negative effects of operating leverage, which resulted in a relatively larger drop in So-Young International's bottom line as compared to its topline contraction. Another key contributing factor is an unfavorable revenue mix, as SY's gross profit declined by -20.8 percentage points YoY to 66.2% in Q2 2022. The new sales of equipment & related maintenance services business segment or Wuhan Miracle Laser System boasted relatively inferior profitability as compared to the company's information services and reservation services business segments. The key operating metrics for So-Young International in the recent quarter were also disappointing. Monthly active users for SY decreased by-20.5% QoQ and -65.0% YoY to 3.5 million for Q2 2022. The total value of transactions executed in So-Young International's community and the number of paying users for SY shrunk by -35.8% YoY and -47.1% YoY to RMB353 million and 129,500, respectively in the recent quarter. Spotlight On So-Young's New Product Moving beyond the short-term headwinds for SY, the spotlight is on So-Young's new product launch.Seeking Alpha • Aug 16
So-Young International GAAP EPADS of -$0.06, revenue of $46.1M beats by $1.01M
So-Young International press release (NASDAQ:SY): Q2 GAAP EPADS of -$0.06. Revenue of $46.1M (-34.1% Y/Y) beats by $1.01M. For the third quarter of 2022, So-Young expects total revenues to be between RMB310 million (US$46.3 million) and RMB330 million (US$49.3 million), representing a 28.1% to 23.5% decrease from the same period in 2021. The above outlook is based on the current market conditions and reflects the Company’s preliminary estimates of market and operating conditions, as well as customer demand, which are all subjected to change, particularly in view of the potential impact of the COVID-19, the effects of which are difficult to analyze and predict.Seeking Alpha • Jul 18
So-Young receives minimum bid price notice from Nasdaq
So-Young International (NASDAQ:SY) has received a notification from Nasdaq indicating that for the last 30 consecutive business days, the closing bid price of the American depositary shares was below the minimum bid price of $1.00 per share. The company is granted a compliance period of 180 calendar days, or until January 11, 2023, to regain compliance under the Nasdaq Listing Rules. If the company does not regain compliance by January 11, 2023, it may be eligible for an additional 180-day compliance period. The Nasdaq notification letter does not affect the company’s business operations, and the company will take all reasonable measures to regain compliance within the prescribed grace period. Shares up 3% PM.Seeking Alpha • Jun 07
So-Young: Highly Attractive Risk-Reward Profile
So-Young is a small-cap internet company in China. The company operates the country’s leading online platform to connect buyers and sellers of medical aesthetic solutions. So-Young has 4.4 million monthly active users, which the company claims to be highly loyal and engaged. Speculators might find significant value based on three pillars: (1) the company can either find growth, (2) sustain/slightly increase profitability (3), or distribute net cash to shareholders. I calculate a fair base-case target price of $4.92/share and assign a Strong BUY recommendation on >400% upside potential. However, given the speculative nature of the trade, I also assign a High-Risk label.Analysartikel • Sep 15
So-Young International Inc.'s (NASDAQ:SY) 27% Cheaper Price Remains In Tune With Earnings
To the annoyance of some shareholders, So-Young International Inc. ( NASDAQ:SY ) shares are down a considerable 27% in...Seeking Alpha • Sep 13
Regulatory Wrinkles Spoil So-Young's Latest Results
So-Young International devotes much of its second-quarter results trying to ease investor concerns over a potential crackdown on China’s cosmetic surgery industry. Company’s revenue rises 37% and profit jumps sharply in latest quarter as business rebounds from year-ago pandemic-induced slowdown. It's quite possible So-Young could ultimately bounce back once the uncertainty lifts and it becomes clear the regulatory clampdown won't intensify.VD OCH KONCERNCHEF
Xing Jin (46 yo)
13.3yrs
Anställning
Mr. Xing Jin is co-founder of So-Young International Inc. and has been its Director and Chief Executive Officer since March 2013 and is its Interim CFO since December 31, 2025. He previously served as Inte...
Ledningsgrupp
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| COO & Director | 1.5yrs | inga uppgifter | 0.090% $ 165.6k | |
| Chief Marketing Officer & Director | 1.5yrs | inga uppgifter | 0.33% $ 606.6k | |
| Co-Founder | 13.3yrs | inga uppgifter | 24.95% $ 46.1m | |
| Co-Founder & Consultant | 13.5yrs | inga uppgifter | inga uppgifter | |
| Investor Relations Officer | no data | inga uppgifter | inga uppgifter | |
| Investor Relations Officer | no data | inga uppgifter | inga uppgifter | |
| Investor Relation Officer | no data | inga uppgifter | inga uppgifter |
7.4yrs
Genomsnittlig anställningstid
43yo
Genomsnittlig ålder
Erfaren ledning: SY s ledningsgrupp är erfaren och erfaren ( 7.4 års genomsnittlig anställning).
Styrelseledamöter
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| COO & Director | 1.1yrs | inga uppgifter | 0.090% $ 165.6k | |
| Chief Marketing Officer & Director | 1.1yrs | inga uppgifter | 0.33% $ 606.6k | |
| Co-Founder | 13.3yrs | inga uppgifter | 24.95% $ 46.1m | |
| Independent Director | 6.6yrs | inga uppgifter | inga uppgifter | |
| Independent Director | 2.8yrs | inga uppgifter | inga uppgifter | |
| Independent Director | 6.2yrs | inga uppgifter | inga uppgifter |
4.5yrs
Genomsnittlig anställningstid
44yo
Genomsnittlig ålder
Erfaren styrelse: SY s styrelse anses vara erfaren ( 4.5 års genomsnittlig mandatperiod).
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/07/16 21:49 |
| Aktiekurs vid dagens slut | 2026/07/16 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
So-Young International Inc. bevakas av 10 analytiker. 2 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Austin Moldow | Canaccord Genuity |
| Guanran Wang | Citic Securities Co., Ltd. |
| null null | Citic Securities Co., Ltd. |